Voloridge Investment Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-52,460
| Closed | -$6.51M | – | 1267 |
|
|
2025
Q1 | $6.51M | Buy |
+52,460
| New | +$6.51M | 0.02% | 704 |
|
|
2024
Q2 | – | Sell |
-11,849
| Closed | -$1.43M | – | 1292 |
|
|
2024
Q1 | $1.43M | Buy |
+11,849
| New | +$1.43M | 0.01% | 914 |
|
|
2023
Q4 | – | Sell |
-1,594
| Closed | -$206K | – | 1314 |
|
|
2023
Q3 | $206K | Sell |
1,594
-5,713
| -78% | -$739K | ﹤0.01% | 1320 |
|
|
2023
Q2 | $906K | Buy |
+7,307
| New | +$906K | ﹤0.01% | 1139 |
|
|
2022
Q1 | – | Sell |
-3,873
| Closed | -$493K | – | 1546 |
|
|
2021
Q4 | $493K | Buy |
+3,873
| New | +$493K | ﹤0.01% | 1409 |
|
|
2021
Q2 | – | Sell |
-1,258
| Closed | -$207K | – | 1692 |
|
|
2021
Q1 | $207K | Sell |
1,258
-16,384
| -93% | -$2.7M | ﹤0.01% | 1322 |
|
|
2020
Q4 | $2.91M | Buy |
+17,642
| New | +$2.91M | 0.02% | 615 |
|
|
2020
Q1 | – | Sell |
-58,939
| Closed | -$8.8M | – | 1236 |
|
|
2019
Q4 | $8.8M | Buy |
58,939
+46,488
| +373% | +$6.94M | 0.17% | 152 |
|
|
2019
Q3 | $1.6M | Buy |
+12,451
| New | +$1.6M | 0.03% | 515 |
|
|
2019
Q1 | – | Sell |
-26,377
| Closed | -$3.27M | – | 994 |
|
|
2018
Q4 | $3.27M | Buy |
+26,377
| New | +$3.27M | 0.15% | 147 |
|
|
2018
Q1 | – | Sell |
-88,750
| Closed | -$12M | – | 569 |
|
|
2017
Q4 | $12M | Buy |
+88,750
| New | +$12M | 0.26% | 94 |
|
|
2016
Q2 | – | Sell |
-54,053
| Closed | -$7.06M | – | 355 |
|
|
2016
Q1 | $7.06M | Buy |
+54,053
| New | +$7.06M | 0.17% | 126 |
|
|
2015
Q4 | – | Sell |
-48,581
| Closed | -$6.45M | – | 242 |
|
|
2015
Q3 | $6.45M | Buy |
+48,581
| New | +$6.45M | 0.3% | 85 |
|
|
2014
Q1 | – | Sell |
-24,005
| Closed | -$3.04M | – | 107 |
|
|
2013
Q4 | $3.04M | Buy |
+24,005
| New | +$3.04M | 0.58% | 54 |
|